Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Insulin-like growth factor 2 (IGF2) as a driving force of exponential expansion in neonatal thymus

ABSTRACT: Insulin-like growth factor 2 (IGF2) as a driving force of exponential expansion in neonatal thymus

PROVIDER: PRJNA1112875 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29070654.fastq.gz	Fastqsanger.gz
	SRR29070655.fastq.gz	Fastqsanger.gz
	SRR29070656.fastq.gz	Fastqsanger.gz
	SRR29070657.fastq.gz	Fastqsanger.gz
	SRR29070658.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

Insulin-like growth factor 2 (IGF2) as a driving force of exponential expansion in neonatal thymus

Project description:Like all organs, the thymus grows in size and function rapidly during development, which comes to a halt after birth. However, the molecular mechanisms behind such a transition in the thymus remain obscure. Using single-cell RNA sequencing (scRNA-seq) of the murine thymic stroma, we identified that major transcriptomic changes occur in the endothelium and mesenchyme across the transition to homeostasis. Differentially expressed gene and intercellular network analyses of temporally resolved scRNA-seq data revealed fibroblast-derived insulin-like growth factor 2 (IGF2) as a candidate driving neonatal thymic expansion. We demonstrated IGF2 activity promotes a cortical TEC-specific proliferation and is tightly regulated at the thymic growth transition. Bulk RNA-seq of human thymi across the transition also revealed IGF2 to drive thymic expansion, suggesting an evolutionarily conserved role. Our study highlights the role of a fibroblast-derived IGF2 in promoting cTEC proliferation, resulting in early thymic expansion that is followed by down-regulation to establish homeostasis.

2025-03-20 | GSE267785 | GEO

Insulin-like growth factor 2 (IGF2) as a Foxn1-independent driving force of exponential expansion in neonatal thymus

Project description:Insulin-like growth factor 2 (IGF2) as a Foxn1-independent driving force of exponential expansion in neonatal thymus

| PRJNA1112436 | ENA

Insulin-like growth factor 2 (IGF2) as a Foxn1-independent driving force of exponential expansion in neonatal thymus

2025-03-19 | GSE267706 | GEO

L1 retrotransposons exploit RNA m6A modification as an evolutionary driving force

Project description:L1 retrotransposons exploit RNA m6A modification as an evolutionary driving force

| PRJNA638973 | ENA

scATAC-seq of fetal thymus

Project description:To investigate the gene regulatory mechanisms driving T cell development, we generated single-cell transcriptomics and chromatin accessibility data from a human fetal thymus sample at 10 weeks of gestation.

2021-11-30 | E-MTAB-9828 | biostudies-arrayexpress

scRNA-seq of human fetal thymus

2021-11-30 | E-MTAB-9840 | biostudies-arrayexpress

Synaptosome proteome IGF2 enhancer knockout mice

Project description:We identified an enhancer element near IGF2 locus that is possibly involved with dopamine function and schizophrenia. A knockout mouse was generated for the enhancer element in the IGF2 locus. We then characterized the striatal synaptosomes ( i.e. biological fraction representing pre- post synaptic nerve terminal)by mass spectometry from WT and Igf2 enhancer KO mice.

2019-05-31 | PXD012786 | Pride

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.

Project description:The transcription factor nuclear factor-κB (NF-κB) has important roles for tumorigenesis, but how it regulates cancer stem cells (CSCs) remains largely unclear. We identified insulin-like growth factor 2 (IGF2) is a key target of NF-κB activated by HER2/HER3 signaling to form tumor spheres in breast cancer cells. The IGF2 receptor, IGF1 R, was expressed at high levels in CSC-enriched populations in primary breast cancer cells. Moreover, IGF2-PI3K (IGF2-phosphatidyl inositol 3 kinase) signaling induced expression of a stemness transcription factor, inhibitor of DNA-binding 1 (ID1), and IGF2 itself. ID1 knockdown greatly reduced IGF2 expression, and tumor sphere formation. Finally, treatment with anti-IGF1/2 antibodies blocked tumorigenesis derived from the IGF1Rhigh CSC-enriched population in a patient-derived xenograft model. Thus, NF-κB may trigger IGF2-ID1-IGF2-positive feedback circuits that allow cancer stem-like cells to appear. Then, they may become addicted to the circuits. As the circuits are the Achilles' heels of CSCs, it will be critical to break them for eradication of CSCs.

2016-09-05 | GSE64073 | GEO

Docosahexaenoic acid (DHA) a driving force regulating gene expression in bluefin tuna (Thunnus thynnus) larvae development.

Project description:Docosahexaenoic acid (DHA) a driving force regulating gene expression in bluefin tuna (Thunnus thynnus) larvae development.

| PRJNA1097605 | ENA

Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity

Project description:Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity

| PRJEB44756 | ENA